Study the effect of oral supplements zinc and magnesium” on diabetes
Phase 3
Recruiting
- Conditions
- Diabetes mellitus type2.Type 2 diabetes mellitus
- Registration Number
- IRCT20190206042646N1
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Individual consent
Diabetic Type 2 Proven by Metabolic Indicators (FBS and 2HBP)
At least 3 years of diabetes history
aged over 20
Exclusion Criteria
- Age over 60
Individual with a history of myocardial infarction
Individual with hypermagnesemia
Individual with hyperzincemia
Patient with diabetic nephropathy
Insulin Consumers
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of hemoglobin A1c in people with type 2 diabetes. Timepoint: Measurement of hemoglobin A1c at baseline, 3 and 6 months after the start of the intervention. Method of measurement: Biochemical analysis by reference laboratory.
- Secondary Outcome Measures
Name Time Method Peripheral neuropathy in patients with type 2 diabetes. Timepoint: Measurement of hemoglobin A1c at baseline, 3 and 6 months after the start of the intervention. Method of measurement: Michigan Neuropathy Survey Instrument(MNSI).